Mr. Gladney has served as President and Chief Executive Officer since November 2015, and Chairman of the Board of Directors since October 2016. Mr. Gladney joined the Company in November 2015 as President-elect and a member of the board of directors. Prior to joining the Company, Mr. Gladney served as Chairman and Chief Executive Officer of Lanx, Inc., a medical device company focused on developing and commercializing innovative devices for spinal surgery. Prior to joining Lanx, Inc., Mr. Gladney was a Healthcare Operating Partner at Norwest Equity Partners (NEP), where he was responsible for strategic planning, business growth, and corporate governance for NEP portfolio companies, and executing new investment opportunities for the firm. Prior to joining NEP, Mr. Gladney served as President and Chief Executive Officer of several medical device companies including Heart Leaflet Technologies and ACIST Medical Systems, both of which were acquired by The Bracco Group. He also served as Chairman, Chief Executive Officer and President of Complex Technologies, a publicly traded orthopedic and health and wellness electro therapy company. Mr. Gladney currently serves on the Board of Directors of ARIA CV, Inc. and has been a member of a number of other private and public company boards. After the sale of Lanx, Inc., he acted as a private investor and small business consultant.
Mr. Youngstrom is the Senior Vice President, Finance and has served as Chief Financial Officer since October 2016. Mr. Youngstrom has over 25 years of strategic financial and operational experience in a variety of medical device companies, most recently having served as Chief Financial Officer and Vice President, Finance at Galil Medical, a leading developer of cryotherapy technology. Prior to Galil Medical, Mr. Youngstrom served as Vice President, Chief Operating Officer, and Chief Financial Officer at DGIMED Ortho, Inc., a developer of orthopedic medical devices. Mr. Youngstrom has previously served as Chief Financial Officer and Vice President, Finance with Anulex Technologies, Enpath Medical, Compex Technologies, Acist Medical Systems, and Cardiotronics.
Dr. Nihalani has served as Chief Technology Officer since May 2017, immediately following the Company’s acquisition of BarioSurg, Inc. From August 2008 to May 2017, Dr. Nihalani served as the Chief Executive Officer of BarioSurg, Inc., a privately held medical device company that developed a minimally invasive and reversible device to treat obesity and glycemic control. Dr. Nihalani holds a medical degree from the University of Nagpur, India.
Mr. Ansari joined the Company as Senior Vice President of Sales in January 2016. Since the acquisition of ReShape Medical, Inc. in October 2017, Mr. Ansari has assumed the position of Vice President of International Sales and US Veterans Administration Hospitals. Mr. Ansari has over 20 years of experience in the medical device industry, having held various senior sales positions at Stryker Corporation, DePuy, Medtronic, Inc., Lanx, Inc., and Globus Medical, Inc. Prior to joining the Company, Mr. Ansari spent two years as the owner of an independent distributor solely selling Biomet products. Prior to this, he served as Senior Vice President of Sales at Lanx, Inc.
Mr. Haggerty served as Vice President US Commercial Sales for ReShape Medical, Inc. since October 2016, and transitioned to ReShape Lifesciences as part of the acquisition. Mr. Haggerty has over 30 years of experience driving revenue growth through alignment of sales and promotional strategies. His experience includes leading the development, launch, and commercial sales of innovative, paradigm-shifting products and technologies within highly competitive medical markets. Prior to joining ReShape Medical, Mr. Haggerty served as Vice President of Sales and Marketing at Ceterix Orthopaedics. Prior to that, he held the position of Vice President of Global Marketing with Covidien, GI Solutions, which acquired the start-up company BARRX Medical, a manufacturer of a medical device treating Barrett’s Esophagus disease, where Mr. Haggerty held both US and global vice president of sales positions. Mr. Haggerty has also held senior sales leadership positions at Gyrus/ACMI, Boston Scientific Endoscopy, and Procter and Gamble.
Ms. Whalen has served as Vice President of Reimbursement since January 2018. With more than 25 years of leadership experience and medical device reimbursement, advocacy, and evidence development, she has held leadership roles at PacifiCare Health Systems, Edwards Lifesciences, World Heart Corp, and Endocare. Prior to joining ReShape Lifesciences, Ms. Whalen was Senior Director of Reimbursement and Health Policy with Acelity LP Inc.